These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 5158678)

  • 1. Anti-hemostatic action of heparin: relationship between topical and intravenous application.
    Magalhàes JR; Unglert CV; Damiani H; Nogueira Filho J
    Acta Physiol Lat Am; 1971; 21(3):209-15. PubMed ID: 5158678
    [No Abstract]   [Full Text] [Related]  

  • 2. Heparin action on bleeding time and its rate of removal from blood in dogs and rabbits.
    Magalhães JR
    Acta Physiol Lat Am; 1969; 19(3):243-8. PubMed ID: 5374277
    [No Abstract]   [Full Text] [Related]  

  • 3. [The influence of the Soviet antimalarial preparation dabequin on the hemostatic system and on the anticoagulant effect of heparin].
    Pomortseva IV; Ovchinnikova LK; Shcheglova NV
    Farmakol Toksikol; 1990; 53(1):59-62. PubMed ID: 2328805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local heparin is superior to systemic heparin in preventing arterial thrombosis.
    Andresen DM; Barker JH; Hjortdal VE
    Microsurgery; 2002; 22(6):265-72. PubMed ID: 12375294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of the joint administration of heparin and chitosan sulfate ether on hemostatic function].
    Drozd NN; Makarov VA; Bashkov GV; Gal'braĭkh LS; Vikhoreva GA; Gorbacheva IN
    Eksp Klin Farmakol; 1996; 59(1):30-3. PubMed ID: 8704629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of the nature and dynamics of hemostatic changes in myocardial infarction. III. Effect of the method of heparin administration on selected parameters of the system of hemostasis].
    Zapolska-Downar D; Borodin M; Gregorczyk J; Chełstowski K; Sprogis W
    Przegl Lek; 1988; 45(6):508-12. PubMed ID: 3252353
    [No Abstract]   [Full Text] [Related]  

  • 7. Heparin-releasable and platelet pools of tissue factor pathway inhibitor in rabbits.
    Warn-Cramer BJ; Maki SL; Rapaport SI
    Thromb Haemost; 1993 Mar; 69(3):221-6. PubMed ID: 8470044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a new potent heparin. 7th communication: A comparative study of a new potent heparin in human after i.v. application.
    Bhargava AS; Wendt H; Günzel P
    Arzneimittelforschung; 1981; 31(2):386-8. PubMed ID: 7194658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sequential changes in haemostatic activity during prolonged surgery and its alteration with continuous heparin infusion].
    Takasugi Y; Arai C; Sumitomo M; Furuya H
    Masui; 2001 Aug; 50(8):847-53. PubMed ID: 11554015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of heparin therapy. Sensitivity of the activated partial thromboplastin time for monitoring the antithrombotic effects of heparin.
    Zucker S; Cathey MH
    J Lab Clin Med; 1969 Feb; 73(2):320-6. PubMed ID: 5764028
    [No Abstract]   [Full Text] [Related]  

  • 11. Reversal of protamine of the prolonged response to intrapulmonary heparin.
    Wright CJ; Mahadoo J; Jaques LB
    Can J Surg; 1981 Mar; 24(2):130-2. PubMed ID: 7225967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effect of intra-arterial versus intravenous heparin on radial artery occlusion after transradial catheterization.
    Pancholy SB
    Am J Cardiol; 2009 Oct; 104(8):1083-5. PubMed ID: 19801029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of the relationship between the hemostasis and hypoglycemic action of intravenous insulin in rabbits.
    Kleniewski J
    Endocrinol Exp; 1973; 7(2):141-6. PubMed ID: 4541074
    [No Abstract]   [Full Text] [Related]  

  • 14. Hemostatic activation under anticoagulant treatment: a comparison of unfractionated heparin vs. nadroparin in the treatment of proximal deep vein thrombosis.
    Stricker H; Marchetti O; Haeberli A; Mombelli G
    Thromb Haemost; 1999 Oct; 82(4):1227-31. PubMed ID: 10544903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Device for the determination of the electrophoretic mobility of cellular blood elements].
    Belokon AN; Popov MP; Gubarev EA; Lakin KM; Efimov VS
    Farmakol Toksikol; 1970; 33(5):634-8. PubMed ID: 5493230
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of heparin in the early post-traumatic period in burns and hemorrhage].
    Kil'diushov AN
    Anesteziol Reanimatol; 1994; (5):26-8. PubMed ID: 7893070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of heparin administration on the plasma protein binding and disposition of propranolol.
    Silber B; Lo M; Riegelman S
    Res Commun Chem Pathol Pharmacol; 1980 Mar; 27(3):419-29. PubMed ID: 7384636
    [No Abstract]   [Full Text] [Related]  

  • 18. Selective anticoagulation with active site blocked factor IXa in synthetic patch vascular repair results in decreased blood loss and operative time.
    Spanier TB; Oz MC; Madigan JD; Rose EA; Stern DM; Nowygrod R; Schmidt AM
    ASAIO J; 1997; 43(5):M526-30. PubMed ID: 9360098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes in hemostatic system indices during hemosorption in healthy dogs].
    Glushkov VA; Vernigorova LA; Kosarenkov VA; Mosina ZM; Chertkov KS
    Biull Eksp Biol Med; 1982 Jul; 94(7):95-8. PubMed ID: 7126836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combined use of terrilytin, sodium salicylate and heparin for the purpose of regulating hemostasis].
    Mamedov IaD; Reĭsh AV
    Probl Gematol Pereliv Krovi; 1981 May; 26(5):52-5. PubMed ID: 6166936
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.